Australia markets open in 5 hours 40 minutes

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7553-0.0747 (-1.55%)
As of 02:15PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 130.26M
Enterprise value 5.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)62.50
Price/book (mrq)1.06
Enterprise value/revenue 5.72
Enterprise value/EBITDA -0.18

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 315.00%
S&P500 52-week change 323.10%
52-week high 324.7100
52-week low 31.6200
50-day moving average 34.7314
200-day moving average 34.5208

Share statistics

Avg vol (3-month) 3264.39k
Avg vol (10-day) 3198.34k
Shares outstanding 527.03M
Implied shares outstanding 627.03M
Float 815.25M
% held by insiders 10.20%
% held by institutions 163.13%
Shares short (15 Apr 2024) 41.29M
Short ratio (15 Apr 2024) 44.09
Short % of float (15 Apr 2024) 47.28%
Short % of shares outstanding (15 Apr 2024) 44.78%
Shares short (prior month 15 Mar 2024) 41.33M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 307 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,916.38%

Management effectiveness

Return on assets (ttm)-26.36%
Return on equity (ttm)-44.55%

Income statement

Revenue (ttm)1.04M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)129.10%
Gross profit (ttm)N/A
EBITDA -33.77M
Net income avi to common (ttm)-32.07M
Diluted EPS (ttm)-2.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)126.56M
Total cash per share (mrq)4.68
Total debt (mrq)2.25M
Total debt/equity (mrq)1.83%
Current ratio (mrq)30.76
Book value per share (mrq)4.56

Cash flow statement

Operating cash flow (ttm)-26.09M
Levered free cash flow (ttm)-18.72M